# Kyndryl Holdings, Inc.: overview

KD · NYSE · CIK 1867072 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/kd.md) · [Financials](/companies/kd/financials.md) · [Filings](/companies/kd/filings.md) · [Insiders](/companies/kd/insiders.md)

Latest reported revenue: [$3.62bn](/filings/0001104659-26-091129.md) for Q1 FY2027, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:Revenues, accession 0001104659-26-091129).

## Last eight quarters

| Line item | Unit | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,774](/filings/0001104659-25-107022.md) | [3,744](/filings/0001104659-26-015743.md) | [3,800 d](/filings/0001104659-26-067881.md) | [3,743](/filings/0001104659-26-091129.md) | [3,721](/filings/0001104659-25-107022.md) | [3,859](/filings/0001104659-26-015743.md) | [3,769 d](/filings/0001104659-26-067881.md) | [3,618](/filings/0001104659-26-091129.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [(1.1%)](/filings/0001104659-25-107022.md) | [5.7%](/filings/0001104659-26-015743.md) | [1.8% d](/filings/0001104659-26-067881.md) | [1.5%](/filings/0001104659-26-091129.md) | [1.8%](/filings/0001104659-25-107022.md) | [1.5%](/filings/0001104659-26-015743.md) | [0.5% d](/filings/0001104659-26-067881.md) | [(1.5%)](/filings/0001104659-26-091129.md) |
| Diluted EPS | $ per share | [(0.19)](/filings/0001104659-25-107022.md) | [0.89](/filings/0001104659-26-015743.md) | not reported | [0.23](/filings/0001104659-26-091129.md) | [0.29](/filings/0001104659-25-107022.md) | [0.25](/filings/0001104659-26-015743.md) | not reported | [(0.25)](/filings/0001104659-26-091129.md) |
| Free cash flow | $m | [15.0 d](/filings/0001104659-25-107022.md) | [151 d](/filings/0001104659-26-015743.md) | [341 d](/filings/0001104659-26-067881.md) | [(267)](/filings/0001104659-26-091129.md) | [17.0 d](/filings/0001104659-25-107022.md) | [208 d](/filings/0001104659-26-015743.md) | [382 d](/filings/0001104659-26-067881.md) | [(459)](/filings/0001104659-26-091129.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [18.7](/filings/0001558370-24-008788.md) | [17.0](/filings/0001104659-26-015713.md) | [16.1](/filings/0001104659-26-067881.md) | [15.1](/filings/0001104659-26-067881.md) | [15.1](/filings/0001104659-26-067881.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [(12.3%)](/filings/0001558370-24-008788.md) | [(8.1%)](/filings/0001104659-26-015713.md) | [(2.1%)](/filings/0001104659-26-067881.md) | [1.7%](/filings/0001104659-26-067881.md) | [1.3%](/filings/0001104659-26-067881.md) |
| Diluted EPS | $ per share | [(10.28)](/filings/0001558370-24-008788.md) | [(6.06)](/filings/0001104659-26-015713.md) | [(1.48)](/filings/0001104659-26-067881.md) | [1.05](/filings/0001104659-26-067881.md) | [0.85](/filings/0001104659-26-067881.md) |
| Free cash flow | $bn | [(0.9)](/filings/0001558370-24-008788.md) | [(0.1)](/filings/0001104659-26-015713.md) | [(0.2)](/filings/0001104659-26-067881.md) | [0.3](/filings/0001104659-26-067881.md) | [0.3](/filings/0001104659-26-067881.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/kd/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $254.1m | 22,466,690 |  | Added +10,290 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $188.7m | 16,681,449 |  | Reduced −267,646 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $160.1m | 14,636,830 |  | Added +2,841,272 |
| [NEUBERGER BERMAN GROUP LLC](/funds/1465109.md) | 2026-06-30 | $122.1m | 10,804,628 |  | Added +413,949 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $115.4m | 10,199,883 |  | Reduced −45,960 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $115.3m | 10,197,748 |  | Added +152,692 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $100.2m | 8,862,810 |  | Added +4,979,294 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $88.1m | 7,792,865 |  | Added +492,925 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $52.7m | 4,583,394 |  | Reduced −8,945 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $45.3m | 4,005,704 |  | Reduced −644,107 |

## Recent filings

[All 411 filings](/companies/kd/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-28 | 16:22 ET | [8-K](/filings/0001104659-26-111380.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-111380 |
| 2026-08-05 | 16:20 ET | [10-Q](/filings/0001104659-26-091129.md) | Quarterly report, period 2026-06-30 | 0001104659-26-091129 |
| 2026-08-05 | 07:23 ET | [8-K](/filings/0001104659-26-090725.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-090725 |
| 2026-07-31 | 16:15 ET | [8-K](/filings/0001104659-26-089216.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-089216 |
| 2026-07-06 | 06:52 ET | [8-K](/filings/0001104659-26-080558.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-080558 |
| 2026-06-16 | 16:30 ET | [DEF 14A](/filings/0001140361-26-025446.md) | Proxy statement, period 2026-07-30 | 0001140361-26-025446 |
| 2026-05-29 | 08:10 ET | [10-K](/filings/0001104659-26-067881.md) | Annual report, period 2026-03-31 | 0001104659-26-067881 |
| 2026-05-06 | 07:09 ET | [8-K](/filings/0001104659-26-055902.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001104659-26-055902 |
| 2026-02-17 | 07:28 ET | [8-K/A](/filings/0001104659-26-015755.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-015755 |
| 2026-02-17 | 07:21 ET | [10-Q](/filings/0001104659-26-015743.md) | Quarterly report, period 2025-12-31 | 0001104659-26-015743 |

## Latest annual report

[Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001104659-26-067881.md), filed May 29, 2026.

## Forecast league

Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/75dd2cbc-60e4-461d-b050-fc8391438ac3)

## About the filer

- CIK: 1867072
- Tickers: KD
- Exchange: NYSE
- SIC code: 7373 Services-Computer Integrated Systems Design
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.